These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Impaired memory B-cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper-IgE syndrome. van de Veen W; Krätz CE; McKenzie CI; Aui PM; Neumann J; van Noesel CJM; Wirz OF; Hagl B; Kröner C; Spielberger BD; Akdis CA; van Zelm MC; Akdis M; Renner ED Allergy; 2019 Dec; 74(12):2394-2405. PubMed ID: 31269238 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of plasmin-treated intravenous gamma-globulin for therapy of Kawasaki syndrome. Hsu CH; Chen MR; Hwang FY; Kao HA; Hung HY; Hsu CH Pediatr Infect Dis J; 1993 Jun; 12(6):509-12. PubMed ID: 8345983 [TBL] [Abstract][Full Text] [Related]
6. Th2 and Th9 responses in patients with chronic mucocutaneous candidiasis and hyper-IgE syndrome. Becker KL; Rösler B; Wang X; Lachmandas E; Kamsteeg M; Jacobs CW; Joosten LA; Netea MG; van de Veerdonk FL Clin Exp Allergy; 2016 Dec; 46(12):1564-1574. PubMed ID: 27474157 [TBL] [Abstract][Full Text] [Related]
7. High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. Wakim M; Alazard M; Yajima A; Speights D; Saxon A; Stiehm ER Ann Allergy Asthma Immunol; 1998 Aug; 81(2):153-8. PubMed ID: 9723561 [TBL] [Abstract][Full Text] [Related]
8. Elevated serum immunoglobulin E (IgE): when to suspect hyper-IgE syndrome-A 10-year pediatric tertiary care center experience. Joshi AY; Iyer VN; Boyce TG; Hagan JB; Park MA; Abraham RS Allergy Asthma Proc; 2009; 30(1):23-7. PubMed ID: 19331717 [TBL] [Abstract][Full Text] [Related]
9. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children. Hagl B; Heinz V; Schlesinger A; Spielberger BD; Sawalle-Belohradsky J; Senn-Rauh M; Magg T; Boos AC; Hönig M; Schwarz K; Dückers G; von Bernuth H; Pache C; Karitnig-Weiss C; Belohradsky BH; Frank J; Niehues T; Wahn V; Albert MH; Wollenberg A; Jansson AF; Renner ED Pediatr Allergy Immunol; 2016 Mar; 27(2):177-84. PubMed ID: 26592211 [TBL] [Abstract][Full Text] [Related]
10. Effect of Kawasaki disease on migration of human umbilical vein endothelial cells. Sakata K; Kita M; Imanishi J; Onouchi Z; Liu Y; Mitsui Y Pediatr Res; 1995 Oct; 38(4):501-5. PubMed ID: 8559600 [TBL] [Abstract][Full Text] [Related]
11. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease. Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408 [TBL] [Abstract][Full Text] [Related]
12. High dose gammaglobulin treatment for atopic dermatitis. Kimata H Arch Dis Child; 1994 Apr; 70(4):335-6. PubMed ID: 8185369 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. Terai M; Shulman ST J Pediatr; 1997 Dec; 131(6):888-93. PubMed ID: 9427895 [TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of vascular leakage in acute Kawasaki disease. Terai M; Honda T; Yasukawa K; Higashi K; Hamada H; Kohno Y Circulation; 2003 Jul; 108(3):325-30. PubMed ID: 12835221 [TBL] [Abstract][Full Text] [Related]
19. Coronary risks after high-dose gamma-globulin in children with Kawasaki disease. Morikawa Y; Ohashi Y; Harada K; Asai T; Okawa S; Nagashima M; Katoh T; Baba K; Furusho K; Okuni M; Osano M Pediatr Int; 2000 Oct; 42(5):464-9. PubMed ID: 11059532 [TBL] [Abstract][Full Text] [Related]
20. Role of omalizumab in a patient with hyper-IgE syndrome and review dermatologic manifestations. Chularojanamontri L; Wimoolchart S; Tuchinda P; Kulthanan K; Kiewjoy N Asian Pac J Allergy Immunol; 2009 Dec; 27(4):233-6. PubMed ID: 20232578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]